Similar articles for PMID: 35110339

Year	Number of Results
1997	1
1999	3
2000	2
2007	1
2008	2
2009	1
2010	1
2011	5
2012	4
2013	8
2014	4
2015	5
2016	9
2017	9
2018	17
2019	15
2020	15
2021	8
2022	9
2023	4
2024	0

1

Survival and prognostic factors in women treated for epithelial ovarian cancer in western region of Saudi Arabia.

Sait KH, Alam MZ, Haque A, Sait HK, Sait MK, Anfinan NM. Sait KH, et al. Saudi Med J. 2022 Feb;43(2):146-155. doi: 10.15537/smj.2022.43.2.20210626. Saudi Med J. 2022. PMID: 35110339 Free PMC article.

2

Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery.

Sørensen SM, Schnack TH, Høgdall C. Sørensen SM, et al. Acta Obstet Gynecol Scand. 2019 Jan;98(1):34-43. doi: 10.1111/aogs.13453. Epub 2018 Oct 26. Acta Obstet Gynecol Scand. 2019. PMID: 30168853 Free article.

3

Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.

Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY. Bristow RE, et al. Gynecol Oncol. 1999 Mar;72(3):278-87. doi: 10.1006/gyno.1998.5145. Gynecol Oncol. 1999. PMID: 10053096

4

Comparison between serous and non-serous ovarian cancer as a prognostic factor in advanced epithelial ovarian carcinoma after primary debulking surgery.

Hosono S, Kajiyama H, Mizuno K, Sakakibara K, Matsuzawa K, Takeda A, Kawai M, Nagasaka T, Kikkawa F. Hosono S, et al. Int J Clin Oncol. 2011 Oct;16(5):524-32. doi: 10.1007/s10147-011-0223-5. Epub 2011 Mar 23. Int J Clin Oncol. 2011. PMID: 21431342

5

A multivariate analysis of the prognostic impact of tumor burden, surgical timing and complexity after complete cytoreduction for advanced ovarian cancer.

Angeles MA, Rychlik A, Cabarrou B, Spagnolo E, Guyon F, Pérez-Benavente A, Gil-Moreno A, Siegrist J, Querleu D, Mery E, Gladieff L, Hernández A, Ferron G, Martinez A. Angeles MA, et al. Gynecol Oncol. 2020 Sep;158(3):614-621. doi: 10.1016/j.ygyno.2020.06.495. Epub 2020 Jul 22. Gynecol Oncol. 2020. PMID: 32709536

6

A Cytoreductive Surgery plus Hyperthermic Intraperitoneal Chemotherapy in Primary Advanced Ovarian Cancer: The First Reported Pilot Experience from Saudi Arabia.

Abu-Zaid A, Alomar O, Alsabban M, Salem H, Al-Badawi IA. Abu-Zaid A, et al. Gulf J Oncolog. 2020 Sep;1(34):19-25. Gulf J Oncolog. 2020. PMID: 33431358

7

Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma.

Hsieh SF, Lau HY, Wu HH, Hsu HC, Twu NF, Cheng WF. Hsieh SF, et al. Int J Environ Res Public Health. 2019 Feb 21;16(4):637. doi: 10.3390/ijerph16040637. Int J Environ Res Public Health. 2019. PMID: 30795566 Free PMC article.

8

Preoperative Leukocytosis as a Prognostic Marker in Endometrioid-Type Endometrial Cancer: A Single-Center Experience from Saudi Arabia.

Salem H, Abu-Zaid A, Aloman O, Abuzaid M, Alsabban M, Elhassan T, Salem A, Alyamani Y, Al-Badawi IA. Salem H, et al. Gulf J Oncolog. 2020 Jan;1(32):51-58. Gulf J Oncolog. 2020. PMID: 32342919

9

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R. Elattar A, et al. Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Cochrane Database Syst Rev. 2011. PMID: 21833960 Free PMC article. Review.

10

Primary debulking surgery versus primary neoadjuvant chemotherapy for high grade advanced stage ovarian cancer: comparison of survivals.

Kobal B, Noventa M, Cvjeticanin B, Barbic M, Meglic L, Herzog M, Bordi G, Vitagliano A, Saccardi C, Skof E. Kobal B, et al. Radiol Oncol. 2018 Sep 11;52(3):307-319. doi: 10.2478/raon-2018-0030. Radiol Oncol. 2018. PMID: 30210049 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year